Emerging infectious diseases and the depopulation of French Polynesia in the 19th century.

por Martin, P M, Combes, C
Publicado 1996

Reply: Is Epstein–Barr virus associated with aggressive forms of breast cancer?

por Mazouni, C, Fina, F, Martin, P-M
Publicado 2011

Sex steroid binding to human lymphocytes plasma membrane.

por Tubiana, N., Derre, M., Carcassonne, Y., Martin, P. M.
Publicado 1984

Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells

por Silvy, M, Giusti, C, Martin, P-M, Berthois, Y
Publicado 2001

Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival

por Desruisseau, S, Palmari, J, Giusti, C, Romain, S, Martin, P-M, Berthois, Y
Publicado 2006

Human breast cancer cells share antigens with the myeloid monocyte lineage.

por Calvo, F., Martin, P. M., Jabrane, N., De Cremoux, P., Magdelenat, H.
Publicado 1987

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

por Bouchet, C., Spyratos, F., Martin, P. M., Hacène, K., Gentile, A., Oglobine, J.
Publicado 1994

SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo

por Berthois, Y, Bourrié, B, Galiègue, S, Vidal, H, Carayon, P, Martin, P M, Casellas, P
Publicado 2003

An epidemic of bloody diarrhea: Escherichia coli O157 emerging in Cameroon?

por Cunin, P, Tedjouka, E, Germani, Y, Ncharre, C, Bercion, R, Morvan, J, Martin, P M
Publicado 1999

Epstein-Barr virus as a marker of biological aggressiveness in breast cancer

por Mazouni, C, Fina, F, Romain, S, Ouafik, L, Bonnier, P, Brandone, J-M, Martin, P-M
Publicado 2011

HIV-1 group O infection in Cameroon, 1986 to 1998.

por Ayouba, A, Mauclère, P, Martin, P M, Cunin, P, Mfoupouendoun, J, Njinku, B, Souquières, S, Simon, F
Publicado 2001

Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry.

por Tubiana, N., Mishal, Z., le Caer, F., Seigneurin, J. M., Berthoix, Y., Martin, P. M., Carcassonne, Y.
Publicado 1986

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

por Foucré, D., Bouchet, C., Hacène, K., Pourreau-Schneider, N., Gentile, A., Martin, P. M., Desplaces, A., Oglobine, J.
Publicado 1991

Abnormal behavior in mice mutant for the Disc1 binding partner, Dixdc1

por Kivimäe, S, Martin, P-M, Kapfhamer, D, Ruan, Y, Heberlein, U, Rubenstein, J L R, Cheyette, B N R
Publicado 2011

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

por Romain, S., Chinot, O., Klijn, J. G., van Putten, W. L., Guirou, O., Look, M., Martin, P. M., Foekens, J. A.
Publicado 1994

A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation

por Martin, P-M, Yang, X, Robin, N, Lam, E, Rabinowitz, J S, Erdman, C A, Quinn, J, Weiss, L A, Hamilton, S P, Kwok, P-Y, Moon, R T, Cheyette, B N R
Publicado 2013

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

por Fina, F, Romain, S, Ouafik, L'H, Palmari, J, Ayed, F Ben, Benharkat, S, Bonnier, P, Spyratos, F, Foekens, J A, Rose, C, Buisson, M, Gérard, H, Reymond, M O, Seigneurin, J M, Martin, P M
Publicado 2001